Health
Enhancement Products Acquires ReplenTish
Product Line and Related Trademarks
- 18 December
2003, 08:31am ET
TEMPE,
Ariz., Dec. 18 /PRNewswire -
Health Enhancement Products, Inc. , a fast
growing nutraceutical company, has acquired
the ReplenTish product line and all related
trademarks. This is believed to be the first
product that seeks to benefit smokers and
secondhand smokers by replenishing the numerous
critical vitamins and minerals the body
loses when a person smokes cigarettes or
inhales smoke as a secondhand smoker. Financial
terms of the transaction were not disclosed.
Howard Baer, Chairman and Chief Executive
Officer of Health Enhancement Products,
Inc., said, "Being an ex-smoker myself,
I know first hand that smoking is one of
the most harmful habits a person can voluntarily
engage in. On top of this, the costs incurred
by the healthcare system and passive secondhand
smokers are estimated to be $150 billion
annually in the U.S. alone. We decided to
acquire the ReplenTish product line and
related trademarks based on the size of
the addressable market worldwide and the
compelling need for such a product line.
While our goal is to build one of the world's
largest, most profitable nutraceutical companies,
it is always a big plus when we can improve
the quality of people's lives along the
way. With ReplenTish, we are confident we
can accomplish both objectives."
"ReplenTish is currently available
for sale exclusively on our websites http://www.heponline.com/
or http://www.replentish.com/ . We expect
to make the product available through prominent
national and online retailers over the next
few quarters."
Selected statistics underscore the dramatically
adverse and costly health effects of smoking
(source: The American Legacy Foundation
as published on http://www.thetruth.com/
and http://www.americanlegacy.org/
)
- Smoking-related
illness costs the U.S. an estimated $150
billion
each year.
- Tobacco kills
more Americans than AIDS, drugs, homicides,
fires, and
auto accidents combined.
- Cigarettes will
eventually kill a third of the people
who use them.
- Tobacco companies
make a product that kills 1,200 Americans
a day.
- Every year,
tobacco-related disease kills over 178,000
women, making it
the largest preventable cause of death
among women in the U.S.
- Worldwide, tobacco
products kill about 4.9 million people
a year.
- About 1 out of
every 5 deaths in the US can be attributed
to tobacco
products.
- Secondhand cigarette
smoke kills about 53,000 Americans a year.
Women who quit smoking at age 35 increase
their life expectancy by about
8 years.
- Approximately
one of every five women in America is
a smoker. 23% of all
adult Americans and 21% of American women
are currently smokers.
- For both men
and women, the risk of having a heart
attack increases with
the number of cigarettes smoked.
- Cigarette smoke
contains the radioactive isotope Polonium-210.
- Heavy smokers
(two packs a day) are twice as likely
as those who smoke
half a pack a day to have a stroke.
- The risk of SIDS
(Sudden Infant Death Syndrome) is greater
among
children who are exposed to secondhand
smoke. In 2000, more than 2,500
infants died of SIDS
- In the first
two years of life, children who are exposed
to secondhand
smoke from parental smoking have more
than a 50% increased risk of
getting bronchitis and pneumonia.
About
Health Enhancement Products, Inc.
Health Enhancement
Products, Inc. (OTC:
HEPI) is a nutraceutical company directed
specifically at the development and marketing
of supplementary health-enhancing products
using only pure, all-natural and herbal
extracts. In particular, Health Enhancement's
products use beneficial herbal extracts,
vitamins, minerals, and botanical extracts
in varying combinations to address common
or specific illnesses.
The Company's sole product is ProAlgaZyme that is produced from an algae grown in 100% distilled water. The algae produces an enzyme as a
means of protecting itself from exposure
to outside disease and harmful bacteria.
The enzyme is then drawn off, filtered,
tested and bottled for consumption. Recent
clinical trials performed by the Company
have indicated that ProAlgaZyme may increase
and activate the white blood cells in individuals
whose white cells are low or inactive, in
effect enhancing the immune system. Heath
Enhancements is currently doing internal
clinical trials on several illnesses and
diseases with ProAlgaZyme, including various
types of cancer, HIV/AIDS, diabetes and
Chronic Fatigue Syndrome.
ReplenTish is currently available for sale
exclusively on
our websites www.heponline.com
or www.replentish.com
.
CONTACTS:
Health Enhancement Products, Inc.
480-385-3800
This press release may contain forward-looking
statements. The words "estimate," "possible" and "seeking" and similar expressions identify forward-looking
statements, which speak only as to the date
the statement was made. The company undertakes
no obligation to publicly update or revise
any forward-looking statements, whether because
of new information, future events, or otherwise.
Forward-looking statements are inherently
subject to risks and uncertainties, some of
which cannot be predicted, or quantified.
Future events and actual results could differ
materially from those set forth in, contemplated
by, or underlying the forward-looking statements.
The risks and uncertainties to which forward-looking
statements are subject include, but are not
limited to, the effect of government regulation,
competition and other material risks.
|